A detailed history of Ontario Teachers Pension Plan Board transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Ontario Teachers Pension Plan Board holds 23,965 shares of GILD stock, worth $2.16 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
23,965
Previous 66,172 63.78%
Holding current value
$2.16 Million
Previous $4.54 Million 55.77%
% of portfolio
0.02%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$66.59 - $83.99 $2.81 Million - $3.54 Million
-42,207 Reduced 63.78%
23,965 $2.01 Million
Q2 2024

Aug 09, 2024

BUY
$63.15 - $72.88 $1.02 Million - $1.18 Million
16,144 Added 32.27%
66,172 $4.54 Million
Q1 2024

May 10, 2024

SELL
$71.58 - $87.29 $459,400 - $560,227
-6,418 Reduced 11.37%
50,028 $3.66 Million
Q4 2023

Feb 09, 2024

SELL
$73.27 - $83.09 $2.55 Million - $2.89 Million
-34,741 Reduced 38.1%
56,446 $4.57 Million
Q3 2023

Nov 13, 2023

BUY
$73.94 - $80.67 $1.64 Million - $1.79 Million
22,150 Added 32.08%
91,187 $6.83 Million
Q2 2023

Aug 11, 2023

BUY
$76.01 - $86.7 $5.25 Million - $5.99 Million
69,037 New
69,037 $5.32 Million
Q1 2023

May 12, 2023

SELL
$77.31 - $88.08 $1.17 Million - $1.33 Million
-15,107 Reduced 29.72%
35,728 $2.96 Million
Q4 2022

Feb 10, 2023

SELL
$62.32 - $89.47 $313,344 - $449,855
-5,028 Reduced 9.0%
50,835 $4.36 Million
Q3 2022

Nov 10, 2022

BUY
$59.54 - $68.01 $999,438 - $1.14 Million
16,786 Added 42.96%
55,863 $3.45 Million
Q2 2022

Aug 12, 2022

BUY
$57.72 - $65.01 $351,803 - $396,235
6,095 Added 18.48%
39,077 $2.42 Million
Q1 2022

May 13, 2022

BUY
$57.92 - $72.58 $1.52 Million - $1.9 Million
26,219 Added 387.68%
32,982 $1.96 Million
Q4 2021

Feb 11, 2022

SELL
$64.88 - $73.64 $150,716 - $171,065
-2,323 Reduced 25.57%
6,763 $491,000
Q3 2021

Nov 12, 2021

SELL
$67.69 - $73.03 $319,158 - $344,336
-4,715 Reduced 34.16%
9,086 $635,000
Q2 2021

Aug 13, 2021

SELL
$63.47 - $69.35 $245,565 - $268,315
-3,869 Reduced 21.9%
13,801 $950,000
Q1 2021

May 14, 2021

SELL
$60.0 - $68.46 $387,720 - $442,388
-6,462 Reduced 26.78%
17,670 $1.14 Million
Q4 2020

Feb 12, 2021

BUY
$56.65 - $64.55 $193,912 - $220,954
3,423 Added 16.53%
24,132 $1.41 Million
Q3 2020

Nov 13, 2020

SELL
$62.1 - $78.08 $817,546 - $1.03 Million
-13,165 Reduced 38.86%
20,709 $1.31 Million
Q2 2020

Aug 11, 2020

SELL
$72.34 - $84.0 $906,926 - $1.05 Million
-12,537 Reduced 27.01%
33,874 $2.61 Million
Q1 2020

May 08, 2020

SELL
$62.63 - $80.22 $3.05 Million - $3.91 Million
-48,719 Reduced 51.21%
46,411 $3.47 Million
Q4 2019

Feb 07, 2020

BUY
$61.62 - $67.78 $860,461 - $946,479
13,964 Added 17.2%
95,130 $6.18 Million
Q3 2019

Nov 08, 2019

SELL
$62.51 - $69.0 $1.08 Million - $1.19 Million
-17,317 Reduced 17.58%
81,166 $5.14 Million
Q2 2019

Aug 09, 2019

BUY
$61.87 - $69.38 $1.22 Million - $1.36 Million
19,655 Added 24.93%
98,483 $6.65 Million
Q1 2019

May 10, 2019

SELL
$62.53 - $70.05 $1.61 Million - $1.8 Million
-25,731 Reduced 24.61%
78,828 $5.13 Million
Q4 2018

Feb 11, 2019

BUY
$60.54 - $79.0 $921,842 - $1.2 Million
15,227 Added 17.05%
104,559 $6.54 Million
Q3 2018

Nov 09, 2018

SELL
$71.28 - $78.92 $3.11 Million - $3.45 Million
-43,666 Reduced 32.83%
89,332 $6.9 Million
Q2 2018

Aug 10, 2018

SELL
$64.88 - $75.68 $5.11 Million - $5.96 Million
-78,806 Reduced 37.21%
132,998 $9.42 Million
Q1 2018

May 11, 2018

BUY
$72.84 - $88.8 $5.52 Million - $6.73 Million
75,807 Added 55.74%
211,804 $16 Million
Q4 2017

Feb 09, 2018

BUY
$71.15 - $83.52 $4.36 Million - $5.12 Million
61,264 Added 81.98%
135,997 $9.74 Million
Q3 2017

Nov 13, 2017

BUY
$72.11 - $85.47 $5.39 Million - $6.39 Million
74,733
74,733 $6.06 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Ontario Teachers Pension Plan Board Portfolio

Follow Ontario Teachers Pension Plan Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ontario Teachers Pension Plan Board, based on Form 13F filings with the SEC.

News

Stay updated on Ontario Teachers Pension Plan Board with notifications on news.